Gregory M Weinhoff Centessa Pharmaceuticals PLC (CNTA) insider trading activity

Gregory M Weinhoff is Chief Business Officer of Centessa Pharmaceuticals plc. Currently has a direct ownership of 145,515 shares of CNTA, which is worth approximately $2.77 Million. The most recent transaction as insider was on Dec 31, 2022, when has been sold 5,303 shares (Ordinary Shares) at a price of $3.1 per share, resulting in proceeds of $16,439. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 146K

20.6% 3M change

47.44% 12M change

Total Value Held $2.77 Million

Gregory M Weinhoff Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 31 2022	SELL Payment of exercise price or tax liability	$16,439 $3.1 p/Share	5,303 Reduced 2.21%	234,697 Ordinary Shares
Oct 03 2022	SELL Open market or private sale	$19,359 $3.95 p/Share	4,901 Reduced 2.08%	231,099 Ordinary Shares
Sep 30 2022	SELL Payment of exercise price or tax liability	$47,948 $4.25 p/Share	11,282 Reduced 4.7%	228,718 Ordinary Shares
Sep 30 2022	SELL Open market or private sale	$16,280 $4.07 p/Share	4,000 Reduced 1.67%	236,000 Ordinary Shares
Jul 01 2022	BUY Grant, award, or other acquisition	-	230,000 Added 48.94%	240,000 Ordinary Shares
Jun 02 2021	BUY Open market or private purchase	$200,000 $20.0 p/Share	10,000 Added 50.0%	10,000 Ordinary Shares

GMW

Gregory M Weinhoff

Chief Business Officer

Cheshire, X0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CNTA shares.

Notify only if

Value

Insider Trading

Get notified when an Centessa Pharmaceuticals PLC insider buys or sells CNTA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Centessa Pharmaceuticals plc

Track Activities on CNTA

Account